Search Results - "Cayanan CS"

Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.

Authors: Brinkkemper, Mitch Kerster, Gius Brouwer, Philip J. M. et al.

Source: PLoS Pathogens. 10/3/2024, Vol. 20 Issue 10, p1-31. 31p.

Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.

Authors: Tong, Tommy D'Addabbo, Alessio Xu, Jiamin et al.

Source: PLoS Pathogens. 8/7/2023, Vol. 19 Issue 8, p1-40. 40p.

Fusogenic structural changes in arenavirus glycoproteins are associated with viroporin activity.

Authors: Zhang, You York, Joanne Brindley, Melinda A. et al.

Source: PLoS Pathogens. 7/26/2023, Vol. 19 Issue 9, p1-26. 26p.

Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review.

Authors: Derking, Ronald Sanders, Rogier W.

Source: Journal of the International AIDS Society. Nov2021 Supplement S1, Vol. 24, p1-12. 12p. 2 Color Photographs, 1 Chart, 1 Graph.

Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.

Authors: Crooks, Emma T. Almanza, Francisco D'Addabbo, Alessio et al.

Source: PLoS Pathogens. 10/22/2021, Vol. 17 Issue 10, p1-39. 39p.

Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes.

Authors: Upadhyay, Chitra Feyznezhad, Roya Cao, Liwei et al.

Source: PLoS Pathogens. 12/28/2020, Vol. 16 Issue 12, p1-31. 31p.

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.

Source: Virology Journal. 2011, Vol. 8 Issue 1, p429-443. 15p. 3 Diagrams, 3 Graphs.

Identification of HIV gp41-specific antibodies that mediate killing of infected cells.

Authors: Williams, Katherine L. Stumpf, Megan Naiman, Nicole Elise et al.

Source: PLoS Pathogens. 2/19/2019, Vol. 15 Issue 2, p1-27. 27p.

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.

Authors: Gach, Johannes S. Gorlani, Andrea Dotsey, Emmanuel Y. et al.

Source: PLoS ONE. 8/8/2016, Vol. 11 Issue 8, p1-17. 17p.

Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies.

Authors: Feng, Yu Tran, Karen Bale, Shridhar et al.

Source: PLoS Pathogens. 8/3/2016, Vol. 12 Issue 8, p1-26. 26p.

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein.

Authors: Hicar, Mark D. Chen, Xuemin Sulli, Chidananda et al.

Source: PLoS ONE. 7/13/2016, Vol. 11 Issue 7, p1-19. 19p.

Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.

Authors: Sloan, Derek D. Lam, Chia-Ying Kao Irrinki, Alivelu et al.

Source: PLoS Pathogens. 11/5/2015, Vol. 11 Issue 11, p1-29. 29p.

Discrete partitioning of HIV-1 Env forms revealed by viral capture.

Authors: Stieh, Daniel J. King, Deborah F. Klein, Katja et al.

Source: Retrovirology. 9/24/2015, Vol. 12 Issue 1, p1-15. 15p.

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.

Authors: Santra, Sampa Tomaras, Georgia D. Warrier, Ranjit et al.

Source: PLoS Pathogens. 8/3/2015, Vol. 11 Issue 8, p1-38. 38p.

Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.

Authors: Reh, Lucia Magnus, Carsten Schanz, Merle et al.

Source: PLoS Pathogens. 7/9/2015, Vol. 11 Issue 7, p1-34. 34p.

Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.

Authors: Crooks, Ema T. Tong, Tommy Chakrabarti, Bimal et al.

Source: PLoS Pathogens. May2015, Vol. 11 Issue 5, p1-34. 34p.

A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.

Authors: Dotsey, Emmanuel Y. Gorlani, Andrea Ingale, Sampat et al.

Source: PLoS ONE. May2015, Vol. 10 Issue 5, p1-20. 20p.

HIV-1 vaccine immunogen design strategies.

Authors: Mann, Jaclyn K. Ndung'u, Thumbi

Source: Virology Journal. 2015, Vol. 12 Issue 1, p1-11. 11p. 1 Diagram, 1 Chart.

Well-Ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties.

Authors: Guenaga, Javier de Val, Natalia Tran, Karen et al.

Source: PLoS Pathogens. Jan2015, Vol. 11 Issue 1, p1-16. 16p.

Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL.

Authors: Isik, Gözde Sliepen, Kwinten van Montfort, Thijs et al.

Source: PLoS ONE. Sep2014, Vol. 9 Issue 9, p1-11. 11p.